Mammoth Biosciences receives first peer-reviewed validation of CRISPR-based COVID-19 test

TechCrunch ist Teil von Verizon Media. Klicken Sie auf ‘Ich stimme zu.‘, um Verizon Media und dessen Partnern Ihre Einwilligung zu geben, Cookies und ähnliche Technik zu nutzen, um auf Ihr Gerät zuzugreifen und Ihre Daten (einschließlich Standort) zu nutzen, um mehr über Ihre Interessen zu erfahren, personalisierte Anzeigen bereitzustellen und deren Effektivität zu messen. […]

As national COVID-19 cases top 1,000, insurers waive treatment fees and US preps stimulus

TechCrunch ist Teil von Verizon Media. Klicken Sie auf ‘Ich stimme zu.‘, um Verizon Media und dessen Partnern Ihre Einwilligung zu geben, Cookies und ähnliche Technik zu nutzen, um auf Ihr Gerät zuzugreifen und Ihre Daten (einschließlich Standort) zu nutzen, um mehr über Ihre Interessen zu erfahren, personalisierte Anzeigen bereitzustellen und deren Effektivität zu messen. […]

Newly launched pet health startup Gallant wants you to bank your dog’s stem cells for $990

With $11 million in funding and a mission to open up the doors of regenerative therapies to dogs across the nation, the Los Angeles-based startup Gallant is now opening its doors for the first time. The company was founded by DogVacay founder and chief executive Aaron Hirschhorn after seeing his own pet’s struggle with debilitating […]

UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon

Cambridge, UK-based biotech startup Mogrify, which is working on systematizing the development of novel cell therapies in areas such as regenerative medicine, has closed an initial $16 million Series A. The raise from investors Ahren Innovation Capital, Parkwalk and 24Haymarket follows a $4M seed in February — taking its total raised to date to $20M. Put simply, Mogrify’s approach […]

DNA Script picks up $38.5 million to make DNA production faster and simpler

DNA Script has raised $38.5 million in new financing to commercialize a process that it claims is the first big leap forward in manufacturing genetic material. The revolution in synthetic biology that’s reshaping industries from medicine to agriculture rests on three, equally important pillars. They include: analytics — the ability to map the genome and […]

China is funding the future of American biotech

Silicon Valley is in the midst of a health craze, and it is being driven by “Eastern” medicine. It’s been a record year for US medical investing, but investors in Beijing and Shanghai are now increasingly leading the largest deals for US life science and biotech companies. In fact, Chinese venture firms have invested more this […]